Incretin mimetics examined at ADA 2008

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1644, 2008-01, pp. : 3-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incretin Mimetics Target Novel Pathways to Treat Type 2 Diabetes

Pharmaceutical & Diagnostic Innovation, Vol. 2, Iss. 4, 2004-09 ,pp. : 18-22

Adis International

Access to resources Recommend Favorite

The Role of Oral Antidiabetic Agents and Incretin Mimetics in Type 2 Diabetic Patients with Non-Alcoholic Fatty Liver Disease

Current Pharmaceutical Design, Vol. 20, Iss. 22, 2014-05 ,pp. : 3705-3715

Bentham Science Publishers

Access to resources Recommend Favorite

Incretin mimetics and dipeptidyl peptidase 4 inhibitors in clinical trials for the treatment of type 2 diabetes

By Mikhail Nasser

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 6, 2008-06 ,pp. : 845-853

Informa Healthcare

Access to resources Recommend Favorite

Superoxide Dismutase Mimetics

By Salvemini D. Muscoli C. Riley D.P. Cuzzocrea S.

Pulmonary Pharmacology & Therapeutics, Vol. 15, Iss. 5, 2002-10 ,pp. : 439-447

Academic Press

Access to resources Recommend Favorite

Mimetics of the Peptide &bgr;-Strand

Mini Reviews in Medicinal Chemistry, Vol. 2, Iss. 5, 2002-10 ,pp. : 433-445

Bentham Science Publishers

Access to resources Recommend Favorite